ERBB3 and neoplasm: In this context, we found that vaccination with the Mv-HER3 candidate inhibited murine 3LL-R3 tumor progression in an experimental metastasis setting, as fewer metastases were observed in the lungs of vaccinated mice compared to unvaccinated mice (Figure 3D).